中文 | English
Return
Total: 494 , 1/50
Show Home Prev Next End page: GO
Author:(Dong-bo XU)

1.Research progress of phosphatidylinositol 3-kinase/AKt signaling pathway and mechanisms of resistance to sorafenib in hepatocellular carcinoma

Jiejie DONG ; Bo ZHAI ; Jun XU

International Journal of Surgery 2015;42(10):709-713

2.Cardiovascular Complications of Terminal Stage Cirrhosis and Related Clinical Significance

Gang DONG ; Bo REN ; Chen XU

Chinese Journal of Bases and Clinics in General Surgery 2003;0(04):-

3.Significance and ways of cultural integration in hospital regrouping

Bo YAN ; Hengjin DONG ; Yuanzhao XU

Chinese Journal of Hospital Administration 1996;0(07):-

4.Overview of a positive study of the feasibility and model of the restructuring of two second-tier hospitals

Bo YAN ; Hengjin DONG ; Yuanzhao XU

Chinese Journal of Hospital Administration 1996;0(02):-

5.Risk Prediction Model and Scoring System Analysis in Patients With Side Branch Occlusion During Coronary Bifurcation Intervention

Yuan HE ; Dong ZHANG ; Dong YIN ; Bo XU ; Kefei DOU

Chinese Circulation Journal 2015;(9):827-832

6.Causes and treatment for delayed hemorrhage after distal radical gastrectomy

Yuqi LUO ; Bo XU ; Minjie WEN ; Haitao YU ; Dong DONG

International Journal of Surgery 2014;41(1):6-9,封3

7.Report of 6 cases of Xp11.2 translocation renal cell carcinoma and literature review

Jie DONG ; Bo CHEN ; Hanzhong LI ; Zhigang JI ; Weifeng XU

Chinese Journal of Urology 2016;37(10):745-748

8.Diagnostic Value of Fine Needle Aspiration Biopsy for Children with Thyroid Nodules

ping, LI ; xu-dong, LI ; yu-bo, REN

Journal of Applied Clinical Pediatrics 2004;0(08):-

9.Satge I clinical study of dose escalation of capecitabine during intensity modulated radiotherapy concurrent chemotherapy for local regional advanced nasopharyngeal carcinoma

Baomin ZHENG ; Yan SUN ; Shukui HAN ; Xiaoxia DONG ; Bo XU

Chinese Journal of Radiological Medicine and Protection 2010;30(3):330-332

10.Rapid europium-sensitized fluorescent determination of ulifloxacin, the active metabolite of prulifloxacin, in human serum and urine

Peng DONG ; Na XU ; Bo FU ; Lei WANG

Journal of Pharmaceutical Analysis 2011;01(1):46-50

Sort by Result Analysis

Display Mode

Output Records




File Type





Total: 494 , 1/50 Show Home Prev Next End page: GO